There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).
Bibliographical noteFunding Information:
Financial support. M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Santé Québec.
Potential conflicts of interest. This article was prepared as part of routine work. S. P. H. reports research funding from Merck. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Sant? Qu?bec.
© 2019 The Author(s) 2019.
- Mycobacterium tuberculosis
- hematopoietic cell transplantation